Risedronate therapy in patients with mild-to-moderate chronic kidney disease with osteoporosis: post-hoc analysis of data from the risedronate phase III clinical trials
Sign Up to like & getrecommendations! Published in 2017 at "BMC Nephrology"
DOI: 10.1186/s12882-017-0478-9
Abstract: BackgroundThe clinical effect of bisphosphonate treatment has not been clearly evaluated by kidney function in Japanese Chronic Kidney Disease (CKD) patients with osteoporosis. This study analyzed the data from three risedronate Japanese phase III trials.… read more here.
Keywords: chronic kidney; kidney disease; risedronate therapy; risedronate ... See more keywords